{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:30:33Z","timestamp":1792873833750,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11906-021-01146-5","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T11:03:09Z","timestamp":1620385389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson\u2019s Disease\u2014a Systematic Review"],"prefix":"10.1007","volume":"23","author":[{"given":"Vasiliki","family":"Katsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Solomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios S.","family":"Antonopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Vlachopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"issue":"2","key":"1146_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ane.12726","volume":"136","author":"Y Balash","year":"2017","unstructured":"Balash Y, Korczyn AD, Knaani J, Migirov AA, Gurevich T. Quality-of-life perception by Parkinson\u2019s disease patients and caregivers. Acta Neurol Scand. 2017;136(2):151\u20134. https:\/\/doi.org\/10.1111\/ane.12726.","journal-title":"Acta Neurol Scand"},{"key":"1146_CR2","doi-asserted-by":"publisher","unstructured":"Williams-Gray CH, Worth PF. Parkinson\u2019s disease. Medicine. 2016. https:\/\/doi.org\/10.1016\/j.mpmed.2016.06.001.","DOI":"10.1016\/j.mpmed.2016.06.001"},{"key":"1146_CR3","first-page":"1","volume":"289","author":"CD Fryar","year":"2017","unstructured":"Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS Data Brief. 2017;289:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"6","key":"1146_CR4","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines [published correction appears in Hypertension. 2018 Jun;71(6):e140-e144]. Hypertension. 2018;71(6):e13\u2013e115. https:\/\/doi.org\/10.1161\/HYP.0000000000000065.","journal-title":"Hypertension"},{"issue":"1","key":"1146_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson\u2019s disease. Rev Neurol (Paris). 2016;172(1):14\u201326. https:\/\/doi.org\/10.1016\/j.neurol.2015.09.012.","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"1146_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mds.25664","volume":"29","author":"GW Duncan","year":"2014","unstructured":"Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, et al. Health-related quality of life in early Parkinson\u2019s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29(2):195\u2013202. https:\/\/doi.org\/10.1002\/mds.25664.","journal-title":"Mov Disord"},{"issue":"13","key":"1146_CR7","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/mds.23834","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, et al. Health-related quality-of-life scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2011;26(13):2371\u201380. https:\/\/doi.org\/10.1002\/mds.23834.","journal-title":"Mov Disord"},{"issue":"1","key":"1146_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00415-018-9104-4","volume":"266","author":"A Romagnolo","year":"2019","unstructured":"Romagnolo A, Zibetti M, Merola A, Canova D, Sarchioto M, Montanaro E, et al. Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study. J Neurol. 2019;266(1):85\u201391. https:\/\/doi.org\/10.1007\/s00415-018-9104-4.","journal-title":"J Neurol"},{"issue":"11","key":"1146_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"\u2022\u2022 Williams-Gray CH, Mason SL, Evans JR, et al. The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry. 2013;84(11):1258\u201364. https:\/\/doi.org\/10.1136\/jnnp-2013-305277The CamPaIGN study was the first prospective study to track Parkinson disease evolution from diagnosis, with a 10-year follow-up, in an unselected population, focusing on three key irreversible milestones: postural instability, dementia and death.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1146_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jch.12938","volume":"19","author":"DL Vetrano","year":"2017","unstructured":"Vetrano DL, Pisciotta MS, Brandi V, Lo Monaco MR, Laudisio A, onder G, et al. Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson\u2019s disease. J Clin Hypertens (Greenwich). 2017;19(4):418\u201323. https:\/\/doi.org\/10.1111\/jch.12938.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"4","key":"1146_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1161\/HYPERTENSIONAHA.115.06981","volume":"67","author":"GF Salles","year":"2016","unstructured":"Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016;67(4):693\u2013700. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06981.","journal-title":"Hypertension."},{"issue":"6","key":"1146_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.115.05913","volume":"66","author":"V Milazzo","year":"2015","unstructured":"\u2022 Milazzo V, Maule S, Di Stefano C, et al. Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension. Hypertension. 2015;66(6):1168\u201375. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05913This is a very interesting study that investigated the presence and the degree of LV hypertrophy and arterial stiffness in AF evaluated the role of BP variability and 24-h BP values in predicting cardiovascular organ damage.","journal-title":"Hypertension"},{"issue":"2","key":"1146_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatr Clin Neurosci. 2002;14(2):223\u201336 discussion 222.","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"2","key":"1146_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich SG, Savitt JM. Parkinson\u2019s disease. Med Clin North Am. 2019;103(2):337\u201350. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.014.","journal-title":"Med Clin North Am"},{"issue":"5","key":"1146_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X.","journal-title":"Lancet Neurol"},{"issue":"6248","key":"1146_CR16","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M. NEURODEGENERATION. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein. Science. 2015;349(6248):1255555. https:\/\/doi.org\/10.1126\/science.1255555.","journal-title":"Science."},{"issue":"9996","key":"1146_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3.","journal-title":"Lancet."},{"key":"1146_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fneur.2019.00363","volume":"10","author":"JJ Mendoza-Vel\u00e1squez","year":"2019","unstructured":"Mendoza-Vel\u00e1squez JJ, Flores-V\u00e1zquez JF, Barr\u00f3n-Vel\u00e1zquez E, Sosa-Ortiz AL, Illigens BW, Siepmann T. Autonomic dysfunction in \u03b1-synucleinopathies. Front Neurol. 2019;10:363. Published 2019 Apr 12. https:\/\/doi.org\/10.3389\/fneur.2019.00363.","journal-title":"Front Neurol"},{"issue":"1-2","key":"1146_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2011.04.012","volume":"310","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA. Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci. 2011;310(1-2):107\u201311. https:\/\/doi.org\/10.1016\/j.jns.2011.04.012.","journal-title":"J Neurol Sci"},{"key":"1146_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol. 2003;157:1015\u201322.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1146_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The Incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292\u2013300. https:\/\/doi.org\/10.1159\/000445751.","journal-title":"Neuroepidemiology."},{"key":"1146_CR22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29:1583\u201390.","journal-title":"Mov Disord"},{"key":"1146_CR23","doi-asserted-by":"publisher","first-page":"1591e601","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591e601.","journal-title":"Mov Disord"},{"issue":"12","key":"1146_CR24","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30(12):1600\u201311. https:\/\/doi.org\/10.1002\/mds.26431.","journal-title":"Mov Disord"},{"key":"1146_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","volume":"80","author":"TK Khoo","year":"2013","unstructured":"Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80:276\u201381.","journal-title":"Neurology"},{"key":"1146_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fneur.2013.00049","volume":"15","author":"E Stuebner","year":"2013","unstructured":"\u2022 Stuebner E, Vichayanrat E, Low DA, Mathias CJ, Isenmann S, Haensch CA. Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson\u2019s disease. Front Neurol. 2013;15:49. https:\/\/doi.org\/10.3389\/fneur.2013.00049\u03a4his study discusses community-based methods, with a particular focus on 24-h ambulatory blood pressure (BP) monitoring in the home setting and consider its advantages and limitations in patients with Parkinson disease.","journal-title":"Front Neurol"},{"key":"1146_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","volume":"310","author":"Y Sharabi","year":"2011","unstructured":"Sharabi Y, Goldstein DS. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. J Neurol Sci. 2011;310:123\u20138.","journal-title":"J Neurol Sci"},{"issue":"12","key":"1146_CR28","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7.","journal-title":"Lancet Neurol"},{"issue":"14","key":"1146_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.119.044948","volume":"141","author":"JH Park","year":"2020","unstructured":"\u2022 Park JH, Kim DH, Park YG, et al. Association of Parkinson disease with risk of cardiovascular disease and all-cause mortality: a nationwide, population-based cohort study. Circulation. 2020;141(14):1205\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044948This is the most recent nationwide, population-based cohort study to evaluate the risk of MI, ischemic stroke, CHF, and all-cause mortality in PD patients that demonstrated that PD patients have higher risks of MI, ischemic stroke, CHF, and all-cause mortality compared to non-PD patients.","journal-title":"Circulation"},{"key":"1146_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/HYPERTENSIONAHA.111.171249","volume":"57","author":"C Qiu","year":"2011","unstructured":"Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension. 2011;57:1094\u2013100.","journal-title":"Hypertension"},{"issue":"1","key":"1146_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Zimmermann J, Sixel-D\u00f6ring F, Focke NK, Wicke T, Ebentheuer J, et al. Baseline predictors for progression 4 years after Parkinson\u2019s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa). Mov Disord. 2019;34(1):67\u201377. https:\/\/doi.org\/10.1002\/mds.27492.","journal-title":"Mov Disord"},{"issue":"5","key":"1146_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10072-012-1251-2","volume":"34","author":"A Mazza","year":"2013","unstructured":"Mazza A, Ravenni R, Antonini A, Casiglia E, Rubello D, Pauletto P. Arterial hypertension, a tricky side of Parkinson\u2019s disease: physiopathology and therapeutic features. Neurol Sci. 2013;34(5):621\u20137. https:\/\/doi.org\/10.1007\/s10072-012-1251-2.","journal-title":"Neurol Sci"},{"key":"1146_CR33","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","volume":"24","author":"P Barone","year":"2009","unstructured":"Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov Disord. 2009;24:1641\u20139.","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"1146_CR34","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol. 2011;26(Suppl 1):S1\u2013S58. https:\/\/doi.org\/10.1007\/s10654-011-9581-6.","journal-title":"Eur J Epidemiol"},{"key":"1146_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","volume":"293","author":"Y Miyake","year":"2010","unstructured":"Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Case-control study of risk of Parkinson\u2019s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan. J Neurol Sci. 2010;293:82\u20136.","journal-title":"J Neurol Sci"},{"key":"1146_CR36","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mds.25028","volume":"27","author":"M Quik","year":"2012","unstructured":"Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease. Mov Disord. 2012;27:947\u201357.","journal-title":"Mov Disord"},{"key":"1146_CR37","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.parkreldis.2015.07.017","volume":"21","author":"K S\u00e4\u00e4ksj\u00e4rvi","year":"2015","unstructured":"S\u00e4\u00e4ksj\u00e4rvi K, Knekt P, M\u00e4nnist\u00f6 S, Lyytinen J, Heli\u00f6vaara M. Prospective study on the components of metabolic syndrome and the incidence of Parkinson\u2019s disease. Parkinsonism Relat Disord. 2015;21:1148\u201355.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1146_CR38","doi-asserted-by":"publisher","first-page":"e98961","DOI":"10.1371\/journal.pone.0098961","volume":"9","author":"Y-C Lee","year":"2014","unstructured":"Lee Y-C, Lin C-H, Wu R-M, Lin J-W, Chang C-H, Lai MS. Antihypertensive agents and risk of Parkinson\u2019s disease: a nationwide cohort study. PLoS One. 2014;9(6):e98961. https:\/\/doi.org\/10.1371\/journal.pone.0098961.","journal-title":"PLoS One"},{"key":"1146_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/aje\/kwr362","volume":"175","author":"B Pasternak","year":"2012","unstructured":"Pasternak B, Svanstr\u00f6m H, Nielsen NM, Fugger L, Melbye M, et al. Use of calcium channel blockers and Parkinson\u2019s disease. Am J Epidemiol. 2012;175:627\u201335.","journal-title":"Am J Epidemiol"},{"key":"1146_CR40","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","volume":"31","author":"E O\u2019Brien","year":"2013","unstructured":"O\u2019Brien E, Parati G, Stergiou G, European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731\u201368. https:\/\/doi.org\/10.1097\/HJH.0b013e328363e964.","journal-title":"J Hypertens"},{"issue":"6","key":"1146_CR41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/brb3.179","volume":"3","author":"T Tsukamoto","year":"2013","unstructured":"Tsukamoto T, Kitano Y, Kuno S. Blood pressure fluctuation and hypertension in patients with Parkinson\u2019s disease. Brain Behav. 2013;3(6):710\u20134. https:\/\/doi.org\/10.1002\/brb3.179.","journal-title":"Brain Behav"},{"key":"1146_CR42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","volume":"15","author":"AJ Espay","year":"2016","unstructured":"Espay AJ, LeWitt PA, Hauser RA, et al. Neurogenic orthostatic hypotension and supine hypertension in Parkinson\u2019s disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol. 2016;15:954\u201366.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1146_CR43","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00415-014-7339-2","volume":"261","author":"A Fanciulli","year":"2014","unstructured":"Fanciulli A, Strano S, Ndayisaba JP, Goebel G, Gioffr\u00e8 L, Rizzo M, et al. Detecting nocturnal hypertension in Parkinson\u2019s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol. 2014;261(7):1291\u20139.","journal-title":"J Neurol"},{"key":"1146_CR44","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/WNL.0b013e31826c1acd","volume":"79","author":"Kim","year":"2012","unstructured":"Kim, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS. Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology. 2012;79:1323\u201331.","journal-title":"Neurology"},{"issue":"6","key":"1146_CR45","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1002\/clc.20722","volume":"33","author":"A Lagi","year":"2010","unstructured":"Lagi A, Spini S. Clinostatic hypertension and orthostatic hypotension. Clin Cardiol. 2010;33(6):E10\u20135. https:\/\/doi.org\/10.1002\/clc.20722.","journal-title":"Clin Cardiol"},{"issue":"4","key":"1146_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00401-007-0193-x","volume":"113","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Bohl JRE, de Vos RAI, del Tredici K. Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113(4):421\u20139.","journal-title":"Acta Neuropathol"},{"issue":"Pt 3","key":"1146_CR47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain. 2008;131(Pt 3):642\u201350.","journal-title":"Brain"},{"issue":"1","key":"1146_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004;318(1):121\u201334.","journal-title":"Cell Tissue Res"},{"issue":"8","key":"1146_CR49","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/mds.21989","volume":"23","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, DelleDonne A, et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson\u2019s disease. Mov Disord. 2008;23(8):1085\u201392.","journal-title":"Mov Disord"},{"issue":"3","key":"1146_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s004010050705","volume":"94","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H. The intermediolateral nucleus and Clarke\u2019s column in Parkinson\u2019s disease. Acta Neuropathol. 1997;94(3):287\u20139.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"1146_CR51","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/mds.10461","volume":"18","author":"F Courbon","year":"2003","unstructured":"Courbon F, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson\u2019s disease. Mov Disord. 2003;18(8):890\u20137.","journal-title":"Mov Disord"},{"issue":"8","key":"1146_CR52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology. 2002;58(8):1247\u201355.","journal-title":"Neurology"},{"issue":"4","key":"1146_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"A Fanciulli","year":"2018","unstructured":"Fanciulli A, Jordan J, Biaggioni I, Calandra\u2013Buonaura G, Cheshire WP, Cortelli P, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018;28(4):355\u201362. https:\/\/doi.org\/10.1007\/s10286-018-0529-8.","journal-title":"Clin Auton Res"},{"key":"1146_CR54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mds.22457","volume":"24","author":"M Matinolli","year":"2009","unstructured":"Matinolli M, Korpelainen JT, Korpelainen R, Sotaniemi KA, Myllyla VV. Orthostatic hypotension, balance and falls in Parkinson\u2019s disease. Mov Disord. 2009;24:745\u201351.","journal-title":"Mov Disord"},{"issue":"9","key":"1146_CR55","doi-asserted-by":"publisher","first-page":"e106808","DOI":"10.1371\/journal.pone.0106808","volume":"9","author":"JH Pasma","year":"2014","unstructured":"Pasma JH, Bijlsma AY, Klip JM, Stijntjes M, Blauw GJ, Muller M, et al. Blood pressure associates with standing balance in elderly outpatients. PLoS One. 2014;9(9):e106808.","journal-title":"PLoS One"},{"key":"1146_CR56","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jacc.2015.06.1084","volume":"66","author":"F Ricci","year":"2015","unstructured":"Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"1146_CR57","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","volume":"17","author":"DC Velseboer","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM. Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011;17:724\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"1146_CR58","first-page":"527","volume":"84","author":"JB Lanier","year":"2011","unstructured":"Lanier JB, Mote MB, Clay EC. Evaluation and management of orthostatic hypotension. Am Fam Physician. 2011;84(5):527\u201336.","journal-title":"Am Fam Physician"},{"issue":"8","key":"1146_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","volume":"17","author":"AD Ha","year":"2011","unstructured":"Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17(8):625\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1146_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.110.161844","volume":"57","author":"H Yatsuya","year":"2011","unstructured":"Yatsuya H, Folsom AR, Alonso A, Gottesman RF, Rose KM, Investigators AS. Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study. Hypertension. 2011;57(2):167\u201373.","journal-title":"Hypertension."},{"key":"1146_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10286-015-0275-0","volume":"25D3","author":"V Milazzo","year":"2015","unstructured":"Milazzo V, Di Stefano C, Milan A, et al. Cardiovascular complications in patients with autonomic failure. Clin Auton Res. 2015;25D3:133\u201340.","journal-title":"Clin Auton Res"},{"issue":"2","key":"1146_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ajh.2010.146","volume":"24","author":"LJ Benvenuto","year":"2011","unstructured":"Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens. 2011;24(2):135\u201344.","journal-title":"Am J Hypertens"},{"issue":"10","key":"1146_CR63","doi-asserted-by":"publisher","first-page":"e008884","DOI":"10.1161\/JAHA.118.008884","volume":"7","author":"SP Juraschek","year":"2018","unstructured":"Juraschek SP, Daya N, Appel LJ, et al. Orthostatic hypotension and risk of clinical and subclinical cardiovascular disease in middle-aged adults. J Am Heart Assoc. 2018;7(10):e008884. Published 2018 May 7. https:\/\/doi.org\/10.1161\/JAHA.118.008884.","journal-title":"J Am Heart Assoc"},{"key":"1146_CR64","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567\u201382.","journal-title":"J Neurol"},{"key":"1146_CR65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/01.HYP.0000081216.11623.C3","volume":"42","author":"DS Goldstein","year":"2003","unstructured":"Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42:136\u201342.","journal-title":"Hypertension"},{"issue":"11","key":"1146_CR66","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1185\/03007995.2015.1087988","volume":"31","author":"A Loavenbruck","year":"2015","unstructured":"Loavenbruck A, Sandroni P. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions. Curr Med Res Opin. 2015;31(11):2095\u2013104.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1146_CR67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/CS20140766","volume":"129","author":"PL Mar","year":"2015","unstructured":"Mar PL, Shibao CA, Garland EM, Black BK, Biaggioni I, Diedrich A, et al. Neurogenic hyperadrenergic orthostatic hypotension: a newly recognized variant of orthostatic hypotension in older adults with elevated norepinephrine (noradrenaline). Clin Sci (Lond). 2015;129(2):107\u201316.","journal-title":"Clin Sci (Lond)"},{"key":"1146_CR68","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.parkreldis.2014.01.003","volume":"20","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Hirayama M, Hara T, Mizutani Y, Suzuki J, Watanabe H, et al. Role ofcardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20:409\u201314.","journal-title":"Parkinsonism Relat Disord"},{"key":"1146_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14802\/jmd.15015","volume":"8","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Kim SJ. 123I-metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders; literature review. J Mov Disord. 2015;8:55\u201366.","journal-title":"J Mov Disord"},{"key":"1146_CR70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.parkreldis.2013.11.001","volume":"20","author":"R Sakakibara","year":"2014","unstructured":"Sakakibara R, Tateno F, Kishi M, Tsuyusaki Y, Terada H, Inaoka T. MIBGmyocardial scintigraphy in pre-motor Parkinson\u2019s disease: a review. Parkinsonism Relat Disord. 2014;20:267\u201373.","journal-title":"Parkinsonism Relat Disord"},{"key":"1146_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","volume":"46","author":"S Jain","year":"2012","unstructured":"Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis. 2012;46:572\u201380.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1146_CR72","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1586\/14737175.6.8.1173","volume":"6","author":"A Pathak","year":"2006","unstructured":"Pathak A, Senard JM. Blood pressure disorders during Parkinson\u2019s disease: epidemiology, pathophysiology and management. Expert Rev Neurother. 2006;6(8):1173\u201380. https:\/\/doi.org\/10.1586\/14737175.6.8.1173.","journal-title":"Expert Rev Neurother"},{"key":"1146_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","volume":"26","author":"A Fanciulli","year":"2016","unstructured":"Fanciulli A, Gobel G, Ndayisaba JP, et al. Supine hypertension in Parkinson\u2019s disease and multiple system atrophy. Clin Auton Res. 2016;26:97\u2013105.","journal-title":"Clin Auton Res"},{"key":"1146_CR74","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","volume":"61","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61:701\u20136.","journal-title":"Hypertension"},{"issue":"2","key":"1146_CR75","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","volume":"67","author":"AC Arnold","year":"2016","unstructured":"Arnold AC, Okamoto LE, Gamboa A, Black BK, Raj SR, Elijovich F, et al. Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension. 2016;67(2):424\u20139.","journal-title":"Hypertension"},{"key":"1146_CR76","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","volume":"54","author":"EM Garland","year":"2009","unstructured":"Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, et al. Renal impairment of pure autonomic failure. Hypertension. 2009;54:1057\u201361.","journal-title":"Hypertension"},{"key":"1146_CR77","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","volume":"37","author":"J Jordan","year":"2019","unstructured":"Jordan J, Fanciulli A, Tank J, Calandra-Buonaura G, Cheshire WP, Cortelli P, et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. J Hypertens. 2019;37:1541\u20136.","journal-title":"J Hypertens"},{"key":"1146_CR78","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/mds.22767","volume":"24","author":"C Schmidt","year":"2009","unstructured":"Schmidt C, Berg D, Herting, Prieur S, Junghanns S, Schweitzer K, et al. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord. 2009;24:2136\u201342.","journal-title":"Mov Disord"},{"issue":"1","key":"1146_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/ajh\/hpv074","volume":"29","author":"SD Pierdomenico","year":"2016","unstructured":"Pierdomenico SD, Pierdomenico AM, Di Tommaso R, et al. Morning blood pressure surge, dipping, and risk of coronary events in elderly treated hypertensive patients. Am J Hypertens. 2016;29(1):39\u201345. https:\/\/doi.org\/10.1093\/ajh\/hpv074.","journal-title":"Am J Hypertens"},{"key":"1146_CR80","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1097\/HJH.0000000000000355","volume":"32","author":"GC Roush","year":"2014","unstructured":"Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, et al. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J Hypertens. 2014;32:2332\u201340. https:\/\/doi.org\/10.1097\/HJH.0000000000000355.","journal-title":"J Hypertens"},{"key":"1146_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/08037051.2011.587280","volume":"20","author":"C Cuspidi","year":"2011","unstructured":"Cuspidi C, Sala C, Valerio C, Negri F, Mancia G. Nocturnal blood pressure in untreated essential hypertensives. Blood Press. 2011;20:335\u201341.","journal-title":"Blood Press"},{"issue":"5","key":"1146_CR82","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/HYPERTENSIONAHA.111.188151","volume":"59","author":"CD Jones","year":"2012","unstructured":"Jones CD, Loehr L, Franceschini N, Rosamond WD, Chang PP, Shahar E, et al. Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Hypertension. 2012;59(5):913\u20138.","journal-title":"Hypertension"},{"key":"1146_CR83","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.06.032","volume":"56","author":"V Milazzo","year":"2018","unstructured":"Milazzo V, Di Stefano C, Vallelonga F, et al. Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Parkinsonism Relat Disord. 2018;56:82\u20137. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.032.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"1146_CR84","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1007\/s00415-013-6859-5","volume":"260","author":"K Berganzo","year":"2013","unstructured":"Berganzo K, Diez-Arrola B, Tijero B, et al. Nocturnal hypertension and dysautonomia in patients with Parkinson\u2019s disease: are they related? J Neurol. 2013;260(7):1752\u20136.","journal-title":"J Neurol"},{"issue":"2","key":"1146_CR85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jbmt.2015.12.008","volume":"20","author":"L Pizzigalli","year":"2016","unstructured":"Pizzigalli L, Micheletti Cremasco M, Mulasso A, Rainoldi A. The contribution of postural balance analysis in older adult fallers: a narrative review. J Bodyw Mov Ther. 2016;20(2):409\u201317. https:\/\/doi.org\/10.1016\/j.jbmt.2015.12.008.","journal-title":"J Bodyw Mov Ther"},{"issue":"2","key":"1146_CR86","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cger.2019.01.008","volume":"35","author":"R Cuevas-Trisan","year":"2019","unstructured":"Cuevas-Trisan R. Balance problems and fall risks in the elderly. Clin Geriatr Med. 2019;35(2):173\u201383. https:\/\/doi.org\/10.1016\/j.cger.2019.01.008.","journal-title":"Clin Geriatr Med"},{"key":"1146_CR87","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.12021","volume":"273","author":"A Fedorowski","year":"2013","unstructured":"Fedorowski A, Melander O. Syndromes of orthostatic intolerance: a hidden danger. J Intern Med. 2013;273:322\u201335.","journal-title":"J Intern Med"},{"issue":"3","key":"1146_CR88","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/08037051.2019.1604067","volume":"28","author":"I Tzur","year":"2019","unstructured":"Tzur I, Izhakian S, Gorelik O. Orthostatic hypotension: definition, classification and evaluation. Blood Press. 2019;28(3):146\u201356. https:\/\/doi.org\/10.1080\/08037051.2019.1604067.","journal-title":"Blood Press"},{"issue":"6","key":"1146_CR89","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.amjmed.2017.11.051","volume":"131","author":"JM Baker","year":"2018","unstructured":"Baker JM. Gait disorders. Am J Med. 2018;131(6):602\u20137. https:\/\/doi.org\/10.1016\/j.amjmed.2017.11.051.","journal-title":"Am J Med"},{"issue":"6","key":"1146_CR90","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/HJH.0000000000002008","volume":"37","author":"F Vallelonga","year":"2019","unstructured":"Vallelonga F, Maule S. Diagnostic and therapeutical management of supine hypertension in autonomic failure: a review of the literature. J Hypertens. 2019;37(6):1102\u201311. https:\/\/doi.org\/10.1097\/HJH.0000000000002008.","journal-title":"J Hypertens"},{"issue":"3","key":"1146_CR91","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","volume":"83","author":"L Norcliffe-Kaufmann","year":"2018","unstructured":"Norcliffe-Kaufmann L, Kaufmann H, Palma JA, Shibao CA, Biaggioni I, Peltier AC, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018;83(3):522\u201331.","journal-title":"Ann Neurol"},{"issue":"5","key":"1146_CR92","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/HJH.0000000000001265","volume":"35","author":"BH Shaw","year":"2017","unstructured":"Shaw BH, Garland EM, Black BK, Paranjape SY, Shibao CA, Okamoto LE, et al. Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a \u201csit-to-stand test\u201d. J Hypertens. 2017;35(5):1019\u201325.","journal-title":"J Hypertens"},{"key":"1146_CR93","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","volume":"32","author":"G Parati","year":"2014","unstructured":"Parati G, Stergiou G, O\u2019Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359\u201366.","journal-title":"J Hypertens"},{"key":"1146_CR94","doi-asserted-by":"publisher","unstructured":"Cremer A, Rousseau A-L, Boulestreau R, Kuntz S, Tzourio C, Gosse P. Screening for orthostatic hypotension using home blood pressure measurements. J Hypertens. https:\/\/doi.org\/10.1097\/HJH.0000000000001986.","DOI":"10.1097\/HJH.0000000000001986"},{"key":"1146_CR95","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1712231","volume":"378","author":"JR Banegas","year":"2018","unstructured":"Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378:1509\u201320.","journal-title":"N Engl J Med"},{"key":"1146_CR96","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/jch.13275","volume":"20","author":"E O\u2019Brien","year":"2018","unstructured":"O\u2019Brien E, White WB, Parati G, Dolan E. Ambulatory blood pressure monitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20:1108\u201311. https:\/\/doi.org\/10.1111\/jch.13275.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"33","key":"1146_CR97","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"key":"1146_CR98","doi-asserted-by":"publisher","unstructured":"Jost WH. What are the considerations for anti-hypertensive treatment in patients with Parkinson\u2019s disease? [published online ahead of print, 2020 Mar 20]. Expert Opin Pharmacother. 2020:1\u20134. https:\/\/doi.org\/10.1080\/14656566.2020.1744565.","DOI":"10.1080\/14656566.2020.1744565"},{"issue":"3","key":"1146_CR99","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1532-5415.2011.03317.x","volume":"59","author":"A Gangavati","year":"2011","unstructured":"Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, Gagnon P, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59(3):383\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"1146_CR100","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/HJH.0000000000001323","volume":"35","author":"G Corrao","year":"2017","unstructured":"Corrao G, Rea F, Monzio Compagnoni M, Merlino L, Mancia G. Protective effects of antihypertensive treatment in patients aged 85 years or older. J Hypertens. 2017;35:1432\u201341.","journal-title":"J Hypertens"},{"issue":"1","key":"1146_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40801-015-0008-7","volume":"2","author":"A Bitner","year":"2015","unstructured":"Bitner A, Zalewski P, Klawe JJ, Newton JL. Drug interactions in Parkinson\u2019s disease: safety of pharmacotherapy for arterial hypertension. Drugs Real World Outcomes. 2015;2(1):1\u201312. https:\/\/doi.org\/10.1007\/s40801-015-0008-7.","journal-title":"Drugs Real World Outcomes"},{"issue":"2","key":"1146_CR102","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/01.HYP.0000153094.09615.11","volume":"45","author":"LA Lipsitz","year":"2005","unstructured":"Lipsitz LA, Gagnon M, Vyas M, Iloputaife I, Kiely DK, Sorond F, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45(2):216\u201321.","journal-title":"Hypertension."},{"issue":"5","key":"1146_CR103","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.hyp.30.5.1062","volume":"30","author":"J Shannon","year":"1997","unstructured":"Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30(5):1062\u20137. https:\/\/doi.org\/10.1161\/01.hyp.30.5.1062.","journal-title":"Hypertension."},{"issue":"6","key":"1146_CR104","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.114.04116","volume":"64","author":"LE Okamoto","year":"2014","unstructured":"Okamoto LE, Gamboa A, Shibao CA, et al. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension. Hypertension. 2014;64(6):1241\u20137. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04116.","journal-title":"Hypertension."},{"issue":"11","key":"1146_CR105","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(11):1294\u2013309. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.079.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1146_CR106","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/14656566.2018.1543404","volume":"20","author":"WP Cheshire","year":"2019","unstructured":"Cheshire WP. Chemical pharmacotherapy for the treatment of orthostatic hypotension. Expert Opin Pharmacother. 2019;20(2):187\u201399. https:\/\/doi.org\/10.1080\/14656566.2018.1543404.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"1146_CR107","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1474-4422(08)70088-7","volume":"7","author":"PA Low","year":"2008","unstructured":"Low PA, Singer W. Management of neurogenic orthostatic hypotension: an update. Lancet Neurol. 2008;7(5):451\u20138.","journal-title":"Lancet Neurol"},{"issue":"21","key":"1146_CR108","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","volume":"39","author":"M Brignole","year":"2018","unstructured":"Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883\u2013948.","journal-title":"Eur Heart J"},{"issue":"10","key":"1146_CR109","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jash.2016.07.010","volume":"10","author":"S Isaacson","year":"2016","unstructured":"Isaacson S, Vernino S, Ziemann A, Rowse GJ, Kalu U, White WB. Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension. J Am Soc Hypertens. 2016;10(10):755\u201362. https:\/\/doi.org\/10.1016\/j.jash.2016.07.010.","journal-title":"J Am Soc Hypertens"},{"key":"1146_CR110","doi-asserted-by":"publisher","first-page":"102659","DOI":"10.1016\/j.autneu.2020.102659","volume":"225","author":"SM Kymes","year":"2020","unstructured":"Kymes SM, Sullivan C, Jackson K, Raj SR. Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension [published online ahead of print, 2020 Feb 28]. Auton Neurosci. 2020;225:102659. https:\/\/doi.org\/10.1016\/j.autneu.2020.102659.","journal-title":"Auton Neurosci"},{"issue":"1","key":"1146_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JPD-130259","volume":"4","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson\u2019s disease (NOH306A). J Parkinsons Dis. 2014;4(1):57\u201365.","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"1146_CR112","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short- term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B). Mov Disord. 2015;30(5):646\u201354.","journal-title":"Mov Disord"},{"issue":"2","key":"1146_CR113","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40265-014-0342-1","volume":"75","author":"GM Keating","year":"2015","unstructured":"Keating GM. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension. Drugs. 2015;75(2):197\u2013206.","journal-title":"Drugs."},{"issue":"3","key":"1146_CR114","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1517\/21678707.2015.1113873","volume":"12","author":"WP Cheshire","year":"2015","unstructured":"Cheshire WP. Droxidopa for neurogenic orthostatic hypotension. Expert Opin Orphan Drugs. 2015;12(3):1479\u201390.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1","key":"1146_CR115","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","volume":"16","author":"DS Goldstein","year":"2006","unstructured":"Goldstein DS. Orthostatic hypotension as an early finding in Parkinson\u2019s disease. Clin Auton Res. 2006;16(1):46\u201354. https:\/\/doi.org\/10.1007\/s10286-006-0317-8.","journal-title":"Clin Auton Res"},{"issue":"4","key":"1146_CR116","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328\u201335. https:\/\/doi.org\/10.1212\/WNL.0000000000000615.","journal-title":"Neurology."},{"issue":"1","key":"1146_CR117","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12883-017-0867-5","volume":"17","author":"I Biaggioni","year":"2017","unstructured":"Biaggioni I, Arthur Hewitt L, Rowse GJ, Kaufmann H. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol. 2017;17(1):90. Published 2017 May 12. https:\/\/doi.org\/10.1186\/s12883-017-0867-5.","journal-title":"BMC Neurol"},{"issue":"8","key":"1146_CR118","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther. 2015;13(8):875\u201391. https:\/\/doi.org\/10.1586\/14779072.2015.1057504.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"1146_CR119","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/jch.13619","volume":"21","author":"KE McDonell","year":"2019","unstructured":"McDonell KE, Preheim BA, Diedrich A, et al. Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients. J Clin Hypertens (Greenwich). 2019;21(9):1308\u201314. https:\/\/doi.org\/10.1111\/jch.13619.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"1146_CR120","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/MBP.0000000000000348","volume":"23","author":"M Heldeweg","year":"2018","unstructured":"Heldeweg M, Jorge P, Ligtenberg J, Ter Maaten JC, Harms M. Orthostatic blood pressure measurements are often overlooked during the initial evaluation of syncope in the emergency department. Blood Press Monit. 2018;23(6):294\u20136.","journal-title":"Blood Press Monit"},{"issue":"11","key":"1146_CR121","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s11606-014-3014-7","volume":"29","author":"W Singer","year":"2014","unstructured":"Singer W, Joyner MJ, Sandroni P, Benarroch EE, Fealey RD, Mandrekar J, et al. Midodrine efficacy in orthostatic hypotension. J Gen Intern Med. 2014;29(11):1440\u20131.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"1146_CR122","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11940-016-0410-9","volume":"18","author":"DI Sinn","year":"2016","unstructured":"Sinn DI, Gibbons CH. Pathophysiology and treatment of orthostatic hypotension in parkinsonian disorders. Curr Treat Options Neurol. 2016;18(6):28. https:\/\/doi.org\/10.1007\/s11940-016-0410-9.","journal-title":"Curr Treat Options Neurol"},{"issue":"19","key":"1146_CR123","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1001\/jama.2010.1695","volume":"304","author":"SS Dhruva","year":"2010","unstructured":"Dhruva SS, Redberg RF. Accelerated approval and possible withdrawal of midodrine. JAMA. 2010;304(19):2172\u20133.","journal-title":"JAMA."},{"key":"1146_CR124","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.0000000000000815","volume":"83D13","author":"A Izcovich","year":"2014","unstructured":"Izcovich A, Gonzalez Malla C, Manzotti M, et al. Midodrine for orthostatic hypotension and recurrentreflex syncope: a systematic review. Neurology. 2014;83D13:1170\u20137.","journal-title":"Neurology"},{"issue":"11","key":"1146_CR125","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","volume":"28","author":"AK Parsaik","year":"2013","unstructured":"Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, et al. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013;28(11):1496\u2013503. https:\/\/doi.org\/10.1007\/s11606-013-2520-3.","journal-title":"J Gen Intern Med"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-021-01146-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T14:29:50Z","timestamp":1675261790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-021-01146-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":125,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1007\/s11906-021-01146-5","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"16 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"26"}}